Literature DB >> 9840530

Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection.

K Shirabe1, M Shimada, K Kajiyama, T Gion, Y Ikeda, H Hasegawa, K Taguchi, K Takenaka, K Sugimachi.   

Abstract

BACKGROUND: This study was performed to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients surviving >10 years after hepatic resection.
METHODS: Between January 1971 and April 1987, 142 patients underwent hepatic resection. Thirty-nine patients who died of surgical morbidity (surgical mortality rate: 27.5%) were excluded from this study. Among the 103 patients who survived and were observed for >10 years after surgery, 12 patients (11.7%) survived >10 years after hepatectomy. The surviving patients were divided into 2 groups: 10-year survivors (n = 12) and nonsurvivors (n = 91). A comparative study between the two groups was made.
RESULTS: Preoperative liver function tests such as the indocyanine green retention test at 15 minutes and albumin levels showed that 10-year survivors had better liver function than nonsurvivors. With regard to virus markers, 5 of 12 patients (41.7%) were positive for hepatitis B surface antigen (HBs-Ag) and the incidence of hepatitis B virus-related HCC was significantly higher than in nonsurvivors (P = 0.020). The results also showed that 4 of 12 long term survivors had hepatitis C virus (HCV) antibody and 1 patient did not have any HCV antibody or HBs-Ag. In two other patients, the HCV antibody was not measured and HBs-Ag was negative. Among four patients with the HCV antibody, the serum HCV RNA concentration, measured by branched DNA probe assay, was <0.5 in 3 patients and 1.72 in 1 patient. Therefore, the HCV RNA concentration tended to be lower in 10-year survivors. Tumor recurrence occurred in 8 of the 10-year survivors. Solitary recurrence was observed in five patients whereas multiple recurrence was observed in three patients. All five patients with solitary recurrence underwent a second resection.
CONCLUSIONS: Based on the results of the current study, good liver function, HBs-Ag positivity, and a low concentration of serum HCV RNA in HCV-related HCC should be considered potentially good predictors of a long term survival.

Entities:  

Mesh:

Year:  1998        PMID: 9840530

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Systematic review of actual 10-year survival following resection for hepatocellular carcinoma.

Authors:  Annelise M Gluer; Nicholas Cocco; Jerome M Laurence; Emma S Johnston; Michael J Hollands; Henry C C Pleass; Arthur J Richardson; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2012-02-28       Impact factor: 3.647

2.  An accurate predictor of liver failure and death after hepatectomy: a single institution's experience with 478 consecutive cases.

Authors:  Zheng-Gui Du; Yong-Gang Wei; Ke-Fei Chen; Bo Li
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.

Authors:  Ken Shirabe; Kazuki Takeishi; Akinobu Taketomi; Hideaki Uchiyama; Hiroto Kayashima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

5.  Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy.

Authors:  Sung Hoon Kim; Sae Byeol Choi; Jae Gil Lee; Seung Up Kim; Mi-Suk Park; Do Young Kim; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2011-02-19       Impact factor: 3.452

6.  Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.

Authors:  Masaki Kaibori; Shoji Kubo; Hiroaki Nagano; Michihiro Hayashi; Seiji Haji; Takuya Nakai; Morihiko Ishizaki; Kosuke Matsui; Takahiro Uenishi; Shigekazu Takemura; Hiroshi Wada; Shigeru Marubashi; Koji Komeda; Fumitoshi Hirokawa; Yasuyuki Nakata; Kazuhisa Uchiyama; A-Hon Kwon
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

7.  Clinical analysis of anatomical resection for the treatment of hepatocellular carcinoma based on the stratification of liver function.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

8.  Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter.

Authors:  Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge
Journal:  Langenbecks Arch Surg       Date:  2008-01-05       Impact factor: 3.445

9.  Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status.

Authors:  Masaki Koda; Shogo Tanaka; Shigekazu Takemura; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Norifumi Kawada; Toshihiko Shibata; Shoji Kubo
Journal:  Liver Cancer       Date:  2018-03-13       Impact factor: 11.740

10.  Mangosteen xanthones suppress hepatitis C virus genome replication.

Authors:  Moonju Choi; Young-Mi Kim; Sungjin Lee; Young-Won Chin; Choongho Lee
Journal:  Virus Genes       Date:  2014-07-02       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.